Drug Shortages Significantly Impact Patient Care and Burden physicians
Recent research published in JAMA Network Open reveals the widespread impact of drug shortages on primary care, with the vast majority of physicians reporting negative consequences for patient care and increased administrative strain. A survey conducted by the American Medical Association, encompassing 902 U.S. primary care physicians between July and August 2024, found that 88% had experienced a drug shortage in the preceding six months.
The study highlights three critical findings. First, 87% of physicians beleive drug shortages negatively effect the quality of care they provide. in response, 92% have altered their prescribed medications, while 63% have delayed prescribing altogether. Second, shortages in specific drug categories are linked to more severe outcomes, particularly within endocrinology (54%), stimulants (52%), and infectious disease treatments (26%). the research demonstrates a significant increase in administrative burden, with 73% of physicians reporting a rise in prior authorization requests due to the need for substitute medications.
Researchers emphasize the challenges posed by adapting care plans in response to shortages, noting the increased workload for staff and limited reimbursement for the additional effort. The necessity of seeking option medications, which may differ from established standards of care or not be covered by patient formularies, further exacerbates the issue, leading to frustration among healthcare providers. This study underscores the urgent need for solutions to mitigate the growing problem of drug shortages and its detrimental effects on both patients and physicians.
Keywords: drug shortages, patient care, primary care physicians, medication access, prior authorization, healthcare administration, endocrinology, stimulants, infectious disease, pharmaceutical supply chain.